114 related articles for article (PubMed ID: 38144525)
1. CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation.
Chatterjee R; Shukla A; Chakrabarti K; Chatterji U
Front Oncol; 2023; 13():1242432. PubMed ID: 38144525
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation.
Chatterjee R; Shukla A; Chakrabarti K; Chatterji U
Front Oncol; 2024; 14():1393626. PubMed ID: 38549942
[TBL] [Abstract][Full Text] [Related]
3. Ethanol extract of propolis and its constituent caffeic acid phenethyl ester inhibit breast cancer cells proliferation in inflammatory microenvironment by inhibiting TLR4 signal pathway and inducing apoptosis and autophagy.
Chang H; Wang Y; Yin X; Liu X; Xuan H
BMC Complement Altern Med; 2017 Sep; 17(1):471. PubMed ID: 28950845
[TBL] [Abstract][Full Text] [Related]
4. CLEC12A plays an important role in immunomodulatory function and prognostic significance of patients with acute myeloid leukemia.
Li Q; Liang C; Xu X; Zhang C; Cao W; Wang M; Jiang Z; Xing H; Yu J
Leuk Lymphoma; 2022 Sep; 63(9):2136-2148. PubMed ID: 35481814
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.
Yang H; Zhou H; Feng P; Zhou X; Wen H; Xie X; Shen H; Zhu X
J Exp Clin Cancer Res; 2010 Jul; 29(1):92. PubMed ID: 20618976
[TBL] [Abstract][Full Text] [Related]
6. Mapping the CLEC12A expression on myeloid progenitors in normal bone marrow; implications for understanding CLEC12A-related cancer stem cell biology.
Bill M; B van Kooten Niekerk P; S Woll P; Laine Herborg L; Stidsholt Roug A; Hokland P; Nederby L
J Cell Mol Med; 2018 Apr; 22(4):2311-2318. PubMed ID: 29411522
[TBL] [Abstract][Full Text] [Related]
7. A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells.
Arvindam US; van Hauten PMM; Schirm D; Schaap N; Hobo W; Blazar BR; Vallera DA; Dolstra H; Felices M; Miller JS
Leukemia; 2021 Jun; 35(6):1586-1596. PubMed ID: 33097838
[TBL] [Abstract][Full Text] [Related]
8. The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia.
Toft-Petersen M; Stidsholt Roug A; Plesner T; Ebbesen L; Brown GD; Nederby L
Cytometry B Clin Cytom; 2018 May; 94(3):520-526. PubMed ID: 28718199
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
Cao Y; Feng YH; Gao LW; Li XY; Jin QX; Wang YY; Xu YY; Jin F; Lu SL; Wei MJ
Int Immunopharmacol; 2019 May; 70():110-116. PubMed ID: 30798159
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the Expression, Oligomerisation and Signaling of the Inhibitory Receptor CLEC12A by Cysteine Residues in the Stalk Region.
Vitry J; Paré G; Murru A; Charest-Morin X; Maaroufi H; McLeish KR; Naccache PH; Fernandes MJ
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638548
[TBL] [Abstract][Full Text] [Related]
11. Intra-tumor ROS amplification by melatonin interferes in the apoptosis-autophagy-inflammation-EMT collusion in the breast tumor microenvironment.
Das N; Mukherjee S; Das A; Gupta P; Bandyopadhyay A; Chattopadhyay S
Heliyon; 2024 Jan; 10(1):e23870. PubMed ID: 38226217
[TBL] [Abstract][Full Text] [Related]
12. Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2/M cell cycle arrest.
Guan X; Guan Y
J BUON; 2020; 25(3):1330-1336. PubMed ID: 32862573
[TBL] [Abstract][Full Text] [Related]
13. The uric acid crystal receptor Clec12A potentiates type I interferon responses.
Li K; Neumann K; Duhan V; Namineni S; Hansen AL; Wartewig T; Kurgyis Z; Holm CK; Heikenwalder M; Lang KS; Ruland J
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18544-18549. PubMed ID: 31451663
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation.
Li J; Feng W; Lu H; Wei Y; Ma S; Wei L; Liu Q; Zhao J; Wei Q; Yao J
J Cell Physiol; 2019 Aug; 234(8):12663-12675. PubMed ID: 30536376
[TBL] [Abstract][Full Text] [Related]
15. The Fusion of
Dhungel BP; Monteuuis G; Giardina C; Tabar MS; Feng Y; Metierre C; Ho S; Nagarajah R; Fontaine ARM; Shah JS; Gokal D; Bailey CG; Schmitz U; Rasko JEJ
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830054
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.
Toft-Petersen M; Nederby L; Kjeldsen E; Kerndrup GB; Brown GD; Hokland P; Stidsholt Roug A
Br J Haematol; 2016 Nov; 175(3):393-401. PubMed ID: 27612176
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma inhibits aldehyde dehydrogenasebright cancer stem cells in the 4T1 mouse model of breast cancer.
Zhuang X; Shi G; Hu X; Wang H; Sun W; Wu Y
Chin Med J (Engl); 2021 Dec; 135(2):194-204. PubMed ID: 34890380
[TBL] [Abstract][Full Text] [Related]
18. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
Hutten TJ; Thordardottir S; Fredrix H; Janssen L; Woestenenk R; Tel J; Joosten B; Cambi A; Heemskerk MH; Franssen GM; Boerman OC; Bakker LB; Jansen JH; Schaap N; Dolstra H; Hobo W
J Immunol; 2016 Oct; 197(7):2715-25. PubMed ID: 27566820
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.
Min L; Wang H; Qi H
Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Su T; Li F; Guan J; Liu L; Huang P; Wang Y; Qi X; Liu Z; Lu L; Wang D
Phytomedicine; 2019 Oct; 63():152968. PubMed ID: 31280140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]